Alterity Therapeutics (ATHE) EPS (Basic) (2016 - 2019)

Alterity Therapeutics has reported EPS (Basic) for 4 years, with the latest figure at -$0.08 in Q4 2019.

• On a quarterly basis, EPS (Basic) rose 12.79% year-over-year to -$0.08 in Q4 2019; TTM through Dec 2019 was -$0.26, a 41.12% increase from a year earlier, with the FY2026 full-year figure at -$937138.0, down 6394.03% from the prior year.
• EPS (Basic) was -$0.08 for Q4 2019 at Alterity Therapeutics, up from -$0.09 in the prior quarter.
• The five-year high for EPS (Basic) was -$0.06 in Q4 2016, with the low at -$0.09 in Q4 2018.
• Average EPS (Basic) over 4 years is -$0.07, with a median of -$0.07 recorded in 2017.
• The sharpest annual moves came in 2018 and 2019: EPS (Basic) slumped 37.71% in 2018, then advanced 12.79% in 2019.
• Over 4 years, EPS (Basic) stood at -$0.06 in 2016, then fell by 1.55% to -$0.06 in 2017, then plunged by 37.71% to -$0.09 in 2018, then rose by 12.79% to -$0.08 in 2019.
• The last three EPS (Basic) figures came in at -$0.08 (Q4 2019), -$0.09 (Q4 2018), and -$0.06 (Q4 2017), per Business Quant data.